MOBILE, Ala. -- (BusinessWire) -- CPSI (NASDAQ: CPSI), a healthcare solutions company, and ChartWise Medical Systems Inc. (ChartWise), a computer-assisted clinical document improvement (CDI) company, today announced a partnership that will help healthcare organizations of all sizes improve clinical documentation accuracy and overall medical reimbursement.

Vericred, based in New York City, is building out a data transfer platform between health insurance carriers and digital health and “insuretech” and “benefittech” firms such as Gusto and Zenefits. Solving for similar types of “digital plumbing” challenges as Plaid did, Vericred may be taking us one step closer to a world in which consumers can easily shop for, compare the costs of in- vs out-of-network visits, and schedule doctor appointments.

By leveraging the ChartWise computer-assisted CDI software, physicians and clinical documentation specialists (CDS) have the tools and guidance necessary to improve documentation quality, resulting in reduced claim denials and more accurate reimbursement.

The collaboration will expand the use of Vivante's digital platform beyond treatment, toward prediction and early interception. Many seemingly healthy people are unknowingly incubating chronic inflammatory diseases. By using clinically relevant data to build a predictive disease model, those who are likely to develop disease or experience disease progression may be identified earlier. A digital medicine platform could then screen large populations, engage more deeply with those who are at increased risk, and potentially deliver meaningful solutions.

Enable Dental announced the closing of its Series A financing in December, led by FCA Venture Partners, to scale its proprietary portable dental solution model. The uniquely developed solution leverages technological advancements in equipment and systems to serve in-need populations including geriatric, special needs, and people who are not well served by a traditional brick and mortar dental office. Enable’s on-premise services have been delivered at independent and assisted living facilities, skilled nursing homes, substance abuse centers, group homes, healthcare institutions, hospitals, and personal residences.

FCA Portfolio Company Vivante will leverage the $5.8 million Series A1 funds to accelerate its bold efforts to provide relief to thousands of Americans who struggle with chronic GI symptoms, using a first-of-its kind digital health solution called GIThrive.